MEET THE TEAM
Bruce has been Chief Executive Officer of Medifirst Solutions, Inc. since March 16, 2011. He has held several key management positions in publicly trading companies. Previous to Medifirst, Mr. Schoengood was the President of NuHealth Solutions and was honored by Mental Health America NJ with the Golden Bell Media Award. He was the Founder, Editor and Publisher of "Successful Child" magazine, an innovative publication devoted to informing and educating parents of children with special needs. Mr. Schoengood worked in the medical education industry consulting for such firms as Haymarket Medical, Physician's Weekly. Genecom and Science & Medicine. Schoengood has also worked as a marketing and advertising consultant for consumer products including health products, cable and internet devices and fashion. With almost three decades of hands-on experience, his expertise extends into all facets of publishing, marketing, advertising: distribution, circulation, printing, production, promotion and creative development.
Dr. Ronald L. Rubin
V P & Medical Director
Dr. Ronald L. Rubin is currently in private practice in Boca Raton, Florida He received his Dental Education at the Howard University College of Dentistry in Washington, D.C. where he was on the Dean's list for 4 years. While there he was granted an Oral Cancer Society Fellowship as well as an externship to the Sloan-Kettering Memorial Cancer Hospital, New York City.
His educational goal was accomplished by his Certification in Oral and Maxillofacial Surgery while attending the prestigious Tufts University – New England Medical Center Hospitals and the Boston City Hospital. He was pleased to add an extra year to his Residency, when he was granted an Oral Cancer Fellowship in Head and Neck Cancer by the American Cancer Society, where he performed experimental research in Radiotherapy Modalities and Applications at the New England Medical Center.
Dr. Rubin is on the Surgical Staff of the Boca Raton Regional Hospital – Active status. Dr Rubin was a founding member of the Dean’s Advisory Board of the Florida Atlantic University College of Medicine, and is an Assistant Professor of Clinical Biomedical Science in their Department of Surgery. Dr Ron Rubin is our Chief Investigator of “The Evaluation of Low Level Laser Therapy - 532nm and 810/830nm on Photorejuvenation and Photobiomodulation, participating with the Institutional Review Board - Division of the FDA.
Dr. Rubin maintains a role in local Community Leadership as well as in the International Rotary Club and Soroptimist Organizations, and participates in the care of Holocaust Survivors and Mason Angel Fund.
Richard is a key advisor to the company and Mr. Schoengood. Richard Berman’s business career spans over 35 years of venture capital, senior management and merger & acquisitions experience. Mr. Berman is a well-respected and seasoned professional, senior executive and public company board member with extensive experience with pharma, healthcare, biotechnology and life sciences companies, in additional to vast experience working in the financial sector. Over the course of his esteemed career, he has served as a director or officer of more than a dozen public and private companies. In 2014, he was elected Chairman of MetaStat Inc. From 2006-2011, he was Chairman of National Investment Managers, a company with $12 billion in pension administration assets. Mr. Berman is a director of four public healthcare companies: Advaxis, Inc., Caladrius Biosciences, Inc., MetaStat Inc. [Chairman] and Cryoport Inc.
From 2002 to 2010, he was a director of Nexmed Inc where he also served as Chairman/CEO in 2008 and 2009 (now called Apricus Biosciences, Inc.). From 1998-2000, he was employed by Internet Commerce Corporation (now Easylink Services) as Chairman and CEO, and was a director from 1998 to 2012. Previously, Mr. Berman worked at Goldman Sachs; was Senior Vice President of Bankers Trust Company, where he started the M&A and Leveraged Buyout Departments; created the largest battery company in the world in the 1980’s by merging Prestolite, General Battery and Exide to form Exide Technologies (XIDE); helped to create what is now Soho (NYC) by developing five buildings; and advised on over $4 billion of M&A transactions in over 300 deals.
Dr. Elliot Ostro
Dr. Ostro is a compassionate and detail-oriented dentist specializing in oral surgery in New York City. Dr. Ostro is certified by the American Board of Oral and Maxillofacial Surgery. He is a member of the American College of Oral and Maxillofacial Surgeons, the American Association of Oral and Maxillofacial, the New York State Dental Society, and the American Dental Society. Dr. Ostro received his medical education from the Washington University School of Dental Medicine. He then participated in an advanced training program in oral maxillofacial surgery at the Boston University Goldman School of Graduate Dentistry. Dr. Ostro provides his patients with services and procedures such as digital X-rays, EMR, extractions, bone grafts, and implants. He treats patients experiencing pain from TMJ, oral cancer, and provides them with oral surgery, jaw correction, implants, and gum surgery. In his spare time, Dr. Ostro enjoys watching hockey and spending time with his friends.